“Are investors supposed to continue to follow a CNS trials process that is clearly a failure or should we just buy lottery tickets instead? “
In reality - what is role of retail investors in trials and outcomes?
95%+ are here just to make money - once the buyout happens - no one cares whether the drug got approval or not. So clearly investors cannot make much noise as they are after money and could care less if the drug is approved and if it is sold at $5000 per dose or $100,000 per year
News 
Market Data 
Discover 
